FDA Approved: NEOSTIGMINE METHYLSULFATE — Original Application (Amphastar Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Amphastar Pharmaceuticals' neostigmine methylsulfate as an original ANDA (ANDA209933) for indications including treatment of myasthenia gravis and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis
• Postoperative Ileus
• Reversal of Nondepolarizing Neuromuscular Blockade After Surgery

Drugs mentioned

• Neostigmine Methylsulfate (neostigmine methylsulfate)

Snippet

ORIG AP for NEOSTIGMINE METHYLSULFATE (NEOSTIGMINE METHYLSULFATE)